Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study page now states that recruitment is closed. Additionally, new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the revision label was updated to v3.6.0.SummaryDifference0.3%

- Check16 days agoChange DetectedThe study page now displays 'Results Submitted' and the page revision is updated to v3.5.5, indicating that results have been submitted. The previous status 'No Results Posted' and revision v3.5.4 are no longer shown.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new published version of the page content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check67 days agoChange DetectedThe location entry for Vienna was updated from 'Vienna, Vienna, Austria, 1140' to 'Vienna, State of Vienna, Austria, 1140', and the page revision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded the disease term Small cell lung carcinoma and the Genetic and Rare Diseases Information Center as a resources entry.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.